A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).
| Image |  |
|---|---|
| Description | scientific article published on 23 May 2013 |
| Author/s |
author: Clara D. Bloomfield Richard M Stone David D. Hurd Richard A. Larson Ravi Vij |
| Publication date | May 23, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |